CR7650A - 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL - Google Patents

2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL

Info

Publication number
CR7650A
CR7650A CR7650A CR7650A CR7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A CR 7650 A CR7650 A CR 7650A
Authority
CR
Costa Rica
Prior art keywords
indol
piperidin
monoclorhydrate
1metil
ilmetil
Prior art date
Application number
CR7650A
Other languages
Spanish (es)
Inventor
Kay Bush Julie
Mary Faul Margaret
Marie Reutzel-Edens Susan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CR7650A priority Critical patent/CR7650A/en
Publication of CR7650A publication Critical patent/CR7650A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a la sal monoclorhidrato de 2,5 -diona-3-(1-metil-1H-indol-3-il)-4-[1-(piridin-2-ilmetil) piperidin-4-il]-1H indol-3-il]-1H-pirrol cristalino, a una formulacion farmaceutica que contenga dicha sal y a procedimientos de tratamiento del cancer y de inhibicion del crecimiento tumoral utilizando dicha sal.Refers to the monohydrochloride salt of 2,5-dione-3- (1-methyl-1H-indol-3-yl) -4- [1- (pyridin-2-ylmethyl) piperidin-4-yl] -1H indole -3-yl] -1H-crystalline pyrrole, to a pharmaceutical formulation containing said salt and to methods of treating cancer and inhibiting tumor growth using said salt.

CR7650A 2005-01-12 2005-01-12 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL CR7650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7650A CR7650A (en) 2005-01-12 2005-01-12 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7650A CR7650A (en) 2005-01-12 2005-01-12 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL

Publications (1)

Publication Number Publication Date
CR7650A true CR7650A (en) 2005-03-11

Family

ID=44839270

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7650A CR7650A (en) 2005-01-12 2005-01-12 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL

Country Status (1)

Country Link
CR (1) CR7650A (en)
  • 2005

Similar Documents

Publication Publication Date Title
ECSP055537A (en) 2,5-DIONA-3- MONOCLORHYDRATE (1-METHYL-1H-INDOL-3-IL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-IL] -1H-INDOL-3-IL ] -1H-CRYSTAL PIRROL
LTPA2017009I1 (en) Bruton tyrosine kinase inhibitors
ECSP066365A (en) ANILINO PURINAS REPLACED IN POSITION 6 USEFUL AS RTK INHIBITORS
UA107667C2 (en) Medical compounds stimulating activity of pyruvate kinase m2, compositions on their basis and use in the treatment of cancer
TW200801008A (en) Protein kinase inhibitors
ECSP099634A (en) USED PIRIDAZINONE DERIVATIVES AS INHIBITORS OF GLUCANO SINTASA
IL191832A (en) Pyridiazinone compounds and their use in the preparation of medicaments for treating tumours
UA99608C2 (en) PDGFRb-SPECIFIC INHIBITORS
GEP20094845B (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
CL2007002167A1 (en) Indole derived compounds, iap antagonists; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
MX361467B (en) Isoindoline compounds for use in the treatment of cancer.
SG155163A1 (en) Pharmacokinetically improved compounds
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
CY1111721T1 (en) ACYLAMIN PYRAZOLA AS FGFR INHIBITORS
EA201000094A1 (en) Derivatives of pyrimidinyl-pyridazinone
DK1654253T3 (en) Substituted 3-pyrrolidine indole derivatives
MY148609A (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
BRPI0908635B8 (en) compound and/or a pharmaceutically acceptable salt thereof and pharmaceutical composition
CA2641347C (en) Indazole-heteroaryl derivatives
MX2008015775A (en) Compounds and compositions for treatment of cancer.
ATE410155T1 (en) USE OF CYCLIN D1 INHIBITORS FOR BREAST CANCER TREATMENT
ATE411981T1 (en) TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE
EA200702136A1 (en) COMPANIES OF STANNSOPORFIN AND THEIR APPLICATION
CR7650A (en) 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL

Legal Events

Date Code Title Description
FC Refusal